Echocardiographic Changes in Infants with Severe Congenital Diaphragmatic Hernia After Fetoscopic Endoluminal

Catherine M Avitabile1,2, Sabrina Flohr3, Leny Mathew3

  • 1Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. avitabilec@chop.edu.

Pediatric Cardiology
|December 13, 2024
PubMed

Insights

Fetoscopic endoluminal tracheal occlusion (FETO) in congenital diaphragmatic hernia (CDH) patients shows improved right ventricular function and less left ventricular hypoplasia. FETO impacts cardiac size and function, with better RV systolic function post-repair.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Neonatology

Background:

  • Congenital diaphragmatic hernia (CDH) poses significant survival challenges.
  • Fetoscopic endoluminal tracheal occlusion (FETO) is a promising intervention to promote lung growth in CDH.
  • The impact of FETO on postnatal cardiac structure and function remains largely uncharacterized.

Purpose of the Study:

  • To evaluate the effects of FETO on right ventricular (RV) and left ventricular (LV) size and function in CDH patients.
  • To compare cardiac parameters between FETO-treated and control CDH patients.
  • To assess changes in cardiac function over time following FETO and CDH repair.

Main Methods:

  • Retrospective cohort study comparing 10 FETO patients with 22 control CDH patients.
  • Quantitative echocardiographic measures including TAPSEZ, RVFAC, RVGLS, RVFWS, RV/LV ratio, LVEI, and LV diastolic/systolic Z-scores were analyzed.
  • Non-parametric tests and linear regression models were used to compare groups and evaluate changes over time.

Main Results:

  • FETO patients initially presented with smaller RV/LV ratios and lower LVEI, indicating less RV dilation and septal displacement.
  • LV hypoplasia was less severe in FETO patients at the first echocardiogram.
  • Post-repair, FETO patients showed significantly improved RV systolic function (RVFAC, RVGLS, RVFWS) compared to controls.

Conclusions:

  • FETO influences postnatal cardiac morphology and function in CDH patients.
  • FETO is associated with reduced RV dilation and LV hypoplasia.
  • Improved RV systolic function is observed in FETO-treated CDH survivors post-repair.